ROGER DIAZ: Open Payments
NPI 1811485154 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 37 payments from 7 companies in 2025. Trend: 2023 $848 · 2024 $1,238 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $351 |
| Axsome Therapeutics, Inc. | 13 | $200 |
| Vanda Pharmaceuticals Inc. | 4 | $87 |
| ABBVIE INC. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 1 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: CAPLYTA, Auvelity, FANAPT, VRAYLAR, AUSTEDO XR, SPRAVATO, REXULTI, Sunosi.
Industry payments across TX — which companies pay providers there.
